Skip to Content

Tong Ren Tang Technologies Co Ltd Class H TNG

Morningstar Rating
€0.60 −0.01 (1.65%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TNG is trading at a 130% premium.
Price
€0.59
Fair Value
€1.48
Uncertainty
Very High
1-Star Price
€8.75
5-Star Price
€7.39
Economic Moat
Lljz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TNG is a good fit for your portfolio.

Trading Information

Previous Close Price
€0.61
Day Range
€0.590.60
52-Week Range
€0.481.00
Bid/Ask
€0.00 / €0.00
Market Cap
€762.07 Mil
Volume/Avg
0 /

Key Statistics

Price/Earnings (Normalized)
9.87
Price/Sales
0.86
Dividend Yield (Trailing)
3.97%
Dividend Yield (Forward)
3.97%
Total Yield
3.97%

Company Profile

Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Mid Value
Total Number of Employees
4,101

Comparables

Valuation

Metric
TNG
03613
601607
Price/Earnings (Normalized)
9.8714.3520.87
Price/Book Value
0.872.010.98
Price/Sales
0.865.100.26
Price/Cash Flow
5.2915.9028.61
Price/Earnings
TNG
03613
601607

Financial Strength

Metric
TNG
03613
601607
Quick Ratio
2.348.491.00
Current Ratio
4.4911.651.34
Interest Coverage
22.74103.864.98
Quick Ratio
TNG
03613
601607

Profitability

Metric
TNG
03613
601607
Return on Assets (Normalized)
7.87%14.28%1.70%
Return on Equity (Normalized)
15.33%16.48%5.27%
Return on Invested Capital (Normalized)
9.03%13.91%3.55%
Return on Assets
TNG
03613
601607
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Eli Lilly and Co
LLY
TnvmqxlsNsv$834.9 Bil
Johnson & Johnson
JNJ
NdvvncddhWyq$350.3 Bil
Merck & Co Inc
MRK
PxsycvbgVtd$327.9 Bil
AbbVie Inc
ABBV
NmlwytqwqWghvn$297.7 Bil
AstraZeneca PLC ADR
AZN
HgggmcsbsYrdl$247.3 Bil
Roche Holding AG ADR
RHHBY
BlqwqcjwvHlbd$223.9 Bil
Novartis AG ADR
NVS
ZdcjmfymBxfpm$216.8 Bil
Amgen Inc
AMGN
QqsyqdmrSlgy$160.2 Bil
Pfizer Inc
PFE
GrpnltpnsSym$156.0 Bil
Sanofi SA ADR
SNY
QpjtqvbrpSrwd$116.1 Bil

Sponsor Center